English
Antimicrobial resistance exhibits remarkable diversity in the European population, providing opportunities to explore both trends and testing. In this presentation, Professor Gian Maria Rossolini offers an overview of the current state of antimicrobial resistance—and detection—in the region.
After viewing this presentation, you will be able to:
After viewing this presentation, you will be able to:
- Understand the diversity of antimicrobial resistance within different European countries
- Explain the presence and regional trends of various microorganisms
- MRSA, which is still highly prevalent in some countries
- Vancomycin-resistant enterococci, which demonstrate diversity among countries with increasing trends
- Carbapenem resistance in Gram-negative bacteria, which is a major and growing problem
- Colistin resistance, which is emerging in carbapenem-resistant Acinetobacter and Klebsiella
- Describe the importance of accurate antimicrobial susceptibility testing and MIC values in detecting resistance
Gian Maria Rossolini is a professor of microbiology and clinical microbiology at the University of Florence, and director of the clinical microbiology and virology unit of Florence Careggi University Hospital. Previously, Prof. Rossolini served as professor of microbiology and clinical microbiology at the University of Siena, where he acted as chairman of the Department of Molecular Biology and as dean of the medical faculty. His main research interests are in the field of antimicrobial agents, microbial drug resistance and diagnostic microbiology. Prof. Rossolini has co-authored more than 400 scientific articles and is named as an inventor in 11 patent applications. He has served as an editor for Antimicrobial Agents and Chemotherapy, and is member of the editorial board of several international journals focused on clinical microbiology and antimicrobial chemotherapy. Prof. Rossolini has been the chairman of the Antimicrobials Committee of the Italian Society of Clinical Microbiologists, and is a member of the Management Board of the Joint Programming Initiative on Antimicrobial Resistance on behalf of the Italian Ministry of University and Research. He has also acted as reviewer/advisor on behalf of national and international funding agencies for the evaluation of research grant applications, and of academic institutions for the evaluation of academic professorships.
